INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against BioAge Labs, Inc. (NASDAQ: BIOA); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of all persons and entities who purchased BioAge Labs, Inc. (NASDAQ: BIOA) (“BioAge” or the “Company”)...

BioAge Labs Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm’s Investigation Block & Leviton is investigating BioAge Labs after the company discontinued its STRIDES Phase 2 trial for azelaprag. Investors should contact the firm.

BioAge Labs, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses Block & Leviton is investigating BioAge Labs, Inc. (Nasdaq: BIOA) for potential securities law violations. Investors should contact the firm to learn more.